Determination of Zn, Cu and Fe in human patients' serum using micro-sampling ICP-MS and sample dilution

46Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A high-throughput, sensitive and rapid method was developed for the determination of Zn, Cu and Fe in small volumes (30 μL) of human serum using inductively coupled plasma mass spectrometry (ICP-MS). The sample preparation procedure employed simple 100-fold dilution of the serum samples with 1.0% butanol, 0.5% v/v ammonia, 0.02% v/v Triton X-100 and 0.01% v/v HNO3. The reliability of the method was evaluated using serum UTAK certified reference material, and the results matched well with the certified values. The method was applied to determine Zn, Cu and Fe in 81 human serum samples from participants in Alzheimer disease (AD) and age-related macular degeneration (AMD) studies. No significant differences were found in Zn and Cu levels between age matched controls, AD and AMD patients. Whilst iron levels appeared marginally higher in the AMD group, compared with the AD group, iron showed larger overall variability than the other two elements.

Cite

CITATION STYLE

APA

Abduljabbar, T. N., Sharp, B. L., Reid, H. J., Barzegar-Befroeid, N., Peto, T., & Lengyel, I. (2019). Determination of Zn, Cu and Fe in human patients’ serum using micro-sampling ICP-MS and sample dilution. Talanta, 204, 663–669. https://doi.org/10.1016/j.talanta.2019.05.098

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free